Shockwave Medical Inc (SWAV) Return on Investment ROI from the first quarter of 2024 to first quarter of 2023 and for the year 2024, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Shockwave Medical Inc   (NASDAQ: SWAV)


Shockwave Medical Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Shockwave Medical Inc's ROI in the first quarter of 2024?
Shockwave Medical Inc achieved a return on average invested assets (ROI) of 12.78 % in its first quarter of 2024, this is above SWAV's average return on investment of -0.52%.
Shockwave Medical Inc invested over the 12 months ending in its first quarter of 2024 $1,279 million

ROI fell compared to the fourth quarter of 2023, despite the net income growth of 24.92% from the fourth quarter of 2023.

Within the Healthcare sector 78 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2023 from 483 to 600.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Investment Change TTM 156.25 % 150.83 % 139.62 % 91.96 % 79.12 %
Y / Y Net Income Change TTM -32.05 % -31.81 % 224.81 % 508.51 % 1556.91 %
Investment (TTM) in Millions 1,551 1,462 1,396 706 641
Return On Investment (TTM) 12.78 % 14.01 % 29.33 % 41.48 % 48.2 %
SWAV's Overall Ranking # 600 # 483 # 189 # 109 # 87
Seq. Investment Change TTM 21.64 % 26.45 % 41.42 % 17.8 % 19.07 %
Seq. Net Income Change TTM 11.01 % -39.61 % -0.01 % 1.37 % 11.39 %
Net Income (TTM) in Millions 163 147 244 244 241

SWAV Company Profile >> Back to SWAV Roi Comparisons >> See Annual SWAV Return On Investment



Return On Investment SWAV's Ranking
Within: No.
Industry # 24
Sector # 79
Overall # 600

Return On Investment Statistics
High Average Low
51.53 %
-0.52 %
-35.82 %
(Dec 31 2022)   (Mar 31 2019)







Financial Statements
Shockwave Medical Inc's I. Quarter Investments $ 1,551 Millions SWAV's Balance sheet
Shockwave Medical Inc's I. Quarter Income $ 55 Millions Quarterly SWAV's Income Statement
SWAV's Income by Division See SWAV's Income by Division


SWAV Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 1,462 583 294 246 208
Y / Y Investment Growth 150.96 % 98.17 % 19.31 % 18.53 % -
Net Income in Millions 147 216 -9 -66 -51
Y / Y Net Income Growth -31.81 % - - - -
Annual Return On Investment 10.07 % 37.07 % -3.11 % -26.66 % -24.58 %


Annual Roi Comment
In the fiscal year 2023 ROI decreased relative to the previous year to 10.07 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SWAV's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SWAV's Competitors
Subscribers only: Roi for Shockwave Medical Inc's Suppliers
Subscribers only: Return On Investment for SWAV's Customers

Other Ratios
SWAV's Roa SWAV's Inventory Turnover Ratio SWAV's Growth Rates SWAV's Dividend Statistics
SWAV's Profitability Ratios SWAV's Asset Turnover Ratio SWAV's Dividend Growth
SWAV's Roe SWAV's Valuation Ratios SWAV's Financial Strength Ratios SWAV's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector ROI
Nrc Health  34.98 %
Mettler toledo International Inc   34.94 %
Earth Science Tech Inc   34.92 %
Star Equity Holdings Inc   33.33 %
Interpace Biosciences Inc   33.18 %
Lantheus Holdings Inc   32.97 %
Lite Strategy Inc   32.16 %
Semler Scientific inc   30.36 %
Alaunos Therapeutics Inc   30.26 %
Johnson and Johnson  29.92 %
Cytomx Therapeutics Inc   28.98 %
Alkermes Plc   25.72 %
Sbc Medical Group Holdings Incorporated  24.59 %
Atlantic Coastal Acquisition Corp Ii  24.45 %
Arcutis Biotherapeutics Inc   24.32 %
Corcept Therapeutics Inc  23.79 %
Iradimed Corporation  23.45 %
Camp4 Therapeutics Corporation  22.66 %
Vertex Pharmaceuticals Inc  21.60 %
Kewaunee Scientific Corporation  21.33 %
Spero Therapeutics Inc   21.20 %
Harmony Biosciences Holdings inc   20.61 %
Chemed Corporation  19.96 %
Dr Reddy s Laboratories Limited  19.09 %
Zoetis Inc   18.95 %
Halozyme Therapeutics Inc   18.75 %
West Pharmaceutical Services Inc   18.21 %
Exelixis Inc   17.86 %
Agilent Technologies inc   17.68 %
Entrada Therapeutics Inc   17.30 %

Date modified: 2026-09-08T15:11:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.